Beloranib

Beloranib · Zafgen, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Beloranib, covering 2012-07-18 to 2016-07-18. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury [Phase 2]